1.
New antimicrobial options for the management of complicated intra-abdominal infections
by Leone, Sebastiano
European journal of clinical microbiology & infectious diseases, 2019, Vol.38 (5), p.819-827
2.
Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections
by Leache, Leire
European journal of clinical microbiology & infectious diseases, 2019, Vol.39 (2), p.361-368
3.
Phosphosulfonic acid-catalyzed green synthesis and bioassay of [alpha]-aryl-[alpha]'-1,3,4-thiadiazolyl aminophosphonates
by Mohan Gundluru
Heteroatom chemistry, 2016, Vol.27 (5), p.269
4.
Identification of an antibacterial protein by functional screening of a human oral metagenomic library
by Arivaradarajan, Preeti
FEMS microbiology letters, 2015, Vol.362 (18), p.fnv142-fnv142
5.
The expanding scope of antimicrobial peptide structures and their modes of action
by Nguyen, Leonard T
Trends in biotechnology (Regular ed.), 2011, Vol.29 (9), p.464-472
6.
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
by Hall, Clayton W
FEMS microbiology reviews, 2017, Vol.41 (3), p.276-301
7.
8.
Photoantimicrobials—are we afraid of the light?
by Wainwright, Mark, Prof
The Lancet infectious diseases, 2016, Vol.17 (2), p.e49-e55
9.
Access to effective antimicrobials: a worldwide challenge
by Laxminarayan, Ramanan, Prof
The Lancet (British edition), 2016, Vol.387 (10014), p.168-175
10.
The role of vaccines in preventing bacterial antimicrobial resistance
by Jansen, Kathrin U
Nature medicine, 2018, Vol.24 (1), p.10-19
11.
Properties and mechanisms of action of naturally occurring antifungal peptides
by van der Weerden, Nicole L
Cellular and molecular life sciences : CMLS, 2013, Vol.70 (19), p.3545-3570
12.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
by Tacconelli, Evelina
The Lancet infectious diseases, 2018, Vol.18 (3), p.318-327
13.
Non-prescription antimicrobial use worldwide: a systematic review
by Morgan, Daniel J, Dr
The Lancet infectious diseases, 2011, Vol.11 (9), p.692-701
14.
Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents
by Allahverdiyev, Adil M
Expert review of anti-infective therapy, 2011, Vol.9 (11), p.1035-1052
15.
Perspectives for clinical use of engineered human host defense antimicrobial peptides
by Pachón-Ibáñez, María Eugenia
FEMS microbiology reviews, 2017, Vol.41 (3), p.323-342
16.
Understanding the mechanisms and drivers of antimicrobial resistance
by Holmes, Alison H, Prof
The Lancet (British edition), 2016, Vol.387 (10014), p.176-187
17.
Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe
by Sharland, Mike
The Lancet infectious diseases, 2018, Vol.18 (1), p.18-20
18.
EUCAST expert rules in antimicrobial susceptibility testing
by Leclercq, R
Clinical microbiology and infection, 2013, Vol.19 (2), p.141-160
19.
Antibacterial properties of nanoparticles
by Hajipour, Mohammad J
Trends in biotechnology (Regular ed.), 2012, Vol.30 (10), p.499-511
20.
Antibacterial surfaces: the quest for a new generation of biomaterials
by Hasan, Jafar
Trends in biotechnology (Regular ed.), 2013, Vol.31 (5), p.295-304
